by University of Melbourne Figure 1. Gender-affirming hormone therapy model induced progressive change in blood DNA methylation. A Longitudinal GAHT model with blood collection at baseline (before hormone therapy), and 6 and 12 months after treatment. In total, samples from 13 transgender women and 13 transgender men were included in the study. B Number of differentially...
Interview conducted by Emily Henderson, B.Sc.Oct 6, 2021 Thought LeadersDr. Yana VinogradovaSenior Research FellowUniversity of Nottingham In this interview, News-Medical speaks to Dr. Yana Vinogradova about her latest research into menopausal hormone therapy (MHT) and its unassociated risk to dementia. What provoked your latest research into menopausal hormone therapy (MHT) and dementia? We have been...
CLEVELAND, Ohio (Oct. 5, 2021)—Although hormone therapy (HT) remains the most effective treatment for menopause symptoms, some women have hesitated to use it because of concerns about various adverse health effects. A new study, however, is reducing some of those concerns, showing no increased risk of heart disease or type 2 diabetes relative to HT...
by University of Oklahoma Credit: CC0 Public Domain For women who are talking to their physicians about hormone therapy for the relief of menopausal symptoms, the decision isn’t always straightforward. Hormone therapy brings an increased risk of cardiovascular disease, but so does midlife itself—simply because of the aging process and an increase in risk factors like...
AMERICAN HEART ASSOCIATION DALLAS, April 19, 2021 — Gender-affirming hormone therapy (GAHT) was associated with blood pressure changes in both transgender men and women, according to new research published today in Hypertension, an American Heart Association journal. Given the higher burden of heart attack, stroke and other cardiovascular conditions among transgender men and women, blood pressure screening and...
THE NORTH AMERICAN MENOPAUSE SOCIETY (NAMS) CLEVELAND, Ohio (March 17, 2021)–As women age, they are more likely to wake up in the middle of the night to pass urine. The loss of estrogen during the menopause transition accelerates this problem, which is known as nocturia. A new study evaluated the effectiveness of different hormone therapies...
by Washington University School of Medicine Bright spots indicate that cancer cells have responded to a one-day challenge with estrogen in this positron emission tomography (PET) scan of a woman with breast cancer. In a small study, researchers at Washington University School of Medicine in St. Louis found that only women whose tumors responded to estrogen challenge benefited...
THE NORTH AMERICAN MENOPAUSE SOCIETY (NAMS) CLEVELAND, Ohio (September 28, 2020)–As one of the most common treatments for effectively managing menopause symptoms, hormone therapy (HT) is also known to provide multiple health benefits, including slowing the progression of atherosclerosis. A study based on Early Versus Late Intervention Trial With Estradiol (ELITE) data evaluated the underlying...
by Memorial Sloan Kettering Cancer Center Micrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia The standard treatment for men with advanced prostate cancer is androgen-deprivation therapy. Androgens are hormones that fuel prostate cell growth; removing them with either drugs or surgery causes the prostate gland to shrink by 90%....
by The North American Menopause Society Skeletal muscle mass and strength are critical in helping prevent falls, fractures, and disability. Yet, they continue to decline during the menopause transition. A new study showed that the prolonged use (defined as ≥13 mo) of hormone therapy (HT) was associated with higher muscle mass and less chance of...
